Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23541756 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations
Condition: Familial Amyotrophic Lateral Sclerosis
Intervention: Drug: ISIS 333611

Indicates status has not been verified in more than two years